Idp Discovery Pharma S.L.

2 trials 1 recruiting Commercial sponsor

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

1 Unique IMPs

N/A Results reported

Phase I/II

Phase I (FiH)

Phase I/II: 1 Phase I (FiH): 1

Oversight events:

1 urgent safety measure across 1 trial

View oversight register →

Top indications

Small cell lung cancer metastatic 1

Top IMPs

All trials

2 total

Phase 1/2 multicenter, two-arms, open-label, dose-escalation study of IDP-121 in combination with chemotherapy in patients with relapsed sma… Pending

2025-521902-17-00 Phase I/II 1 country IDP-121
Phase 1/2 multicenter, open-label, dose-escalation study of IDP-121 in patients with relapsed/refractory hematologic malignancies (CASSANDRA… Recruiting

2024-519194-19-00 Phase I (FiH) 1 country IDP-121

Showing 1–2 of 2 trials

← All sponsors A–Z